Diabetes management partner interface for wireless communication of analyte data
Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.
1. A system comprising:
a display device and a partner device, the display device configured to provide information regarding analyte values in a user's body and in wireless communication with an analyte sensor system and the partner device, wherein the partner device is an insulin delivery device and is not directly connected to the analyte sensor system, and wherein:
the display device receives analyte data from the analyte sensor system;
the partner device delivers insulin to a user based on analyte data generated using the analyte sensor system, or data derived therefrom, that is received from the display device;
the display device alerts the user and provides analyte data received from the analyte sensor system; and
the display device provides information relating to delivery of insulin by the partner device.
2. The system of claim 1 , wherein the display device has an analyte sensor application thereon that is configured to receive medicament-related data from the insulin delivery device and the display device is further configured to provide the medicament-related data to the user.
3. The system of claim 2 , wherein the analyte sensor application is configured to receive the medicament-related data periodically from the insulin delivery device using a continuous connection model.
4. The system of claim 1 , wherein the display device has an analyte sensor application thereon, wherein the display device is further configured to store volumes of analyte-related data received from analyte sensor system and volumes of medicament-related data received from the insulin delivery device, and wherein the analyte sensor application is configured to receive input and allow a user to interact with the analyte-related data and medicament-related data via a graphical user interface of the display device.
5. The system of claim 1 , wherein the display device is further configured to trigger alerts based on events or conditions detected at the insulin delivery device.
6. The system of claim 5 , wherein the display device is configured to trigger an alert if the display device determines that the insulin delivery device has a mechanical or other failure.
7. The system of claim 1 , wherein the display device is further configured to trigger an alert based on characteristics of the analyte data generated using the analyte sensor system.
8. The system of claim 7 , wherein the alert is a hypoglycemic alert that is triggered based on alert conditions indicating a minimum glucose level or based on alert conditions indicating a minimum required trend is present in the user's glucose level.
9. The system of claim 1 , wherein the display device is configured to communicate with the analyte sensor system using a continuous connection model which involves the display device performing an initial pairing with the analyte sensor system, after which the display device remains connected to the analyte sensor system by periodically exchanging messaging with the analyte sensor system to maintain the connection.
10. The system of claim 9 , wherein the display device is configured to communicate with the analyte sensor system according to the continuous connection model by:
receiving advertisement messages transmitted by the analyte sensor system;
establishing a connection with the analyte sensor system;
periodically exchanging data with the analyte sensor system; and
periodically exchanging ping messaging with the analyte sensor system to maintain the connection.
11. The system of claim 9 , wherein the display device is further configured such that, upon the display device becoming disconnected from the analyte sensor system, the user receives a notification via the display device that the connection has been lost.
12. The system of claim 1 , wherein the display device is further configured to utilize a wide area network (WAN) to provide at least one of analyte information, medicament delivery information or information related to use of the insulin delivery device to an electronic device of a follower of the user of the analyte sensor system.
13. The system of claim 12 , wherein the system further comprises the electronic device of the follower, and wherein the electronic device of the follower runs an application specifically designed for following the user.
14. The system of claim 13 , wherein the application on the electronic device of the follower provides one or more of alerts, insulin values, insulin visualization and continuous glucose monitoring (CGM) values.
15. The system of claim 12 , wherein the analyte information is glucose data, and the medicament delivery information is insulin data.
16. The system of claim 1 , wherein the partner device is configured to deliver insulin to a user based on analyte data generated using the analyte sensor system, or data derived therefrom, by delivering a bolus of insulin to a user based on one or more bolus calculation parameters.
17. The system of claim 16 , wherein the partner device is provided access to the one or more bolus calculation parameters.